Top section
Top section
◆ Have capital markets comprehended the heatwave? ◆ Which SSA issuers need to get it done this autumn ◆ Halcyon days for MTN, M&A and ECM bankers
Investors pay little heed to alarming worsening of climate
New $75m partnership to develop treatment for lymphoma was “catalyst for investors”
More articles
More articles
More articles
-
Sirius Minerals has launched a bold $3.8bn financing transaction, combining equity, debt and a new loan facility, to fund the development of its Yorkshire potash mine project. JP Morgan, Sirius's corporate broker, is underwriting and organising the deal. -
A year ago, Hong Kong’s stock exchange (HKEX) added a new chapter to its regulations, allowing pre-revenue biotechnology companies to list. The historic move has turned the city into the biotech IPO hub of Asia. But its fortune could change if the Mainland’s new Nasdaq-style Shanghai tech board, which offers similar pre-revenue concessions, stems the flow of its primarily Chinese issuers.
-
Duiba Group has completed its second attempt at listing on the Hong Kong Stock Exchange.
-
Manulife US Real Estate Investment Trust (Reit) has concluded its placement of new units on the Singapore Exchange.
-
Goldman Sachs has hired Sushil Krishan, a UniCredit banker, for its team covering equity derivatives solutions, GlobalCapital understands.
-
EPP NV, a Polish firm that owns malls and office buildings, raised over €90m of equity capital in Johannesburg on Wednesday last week.
Sub-sections
shared comment list
